Table 2.
Participant characteristics
| Variable | Persons with rheumatoid arthritis (n = 93) |
|---|---|
| Women | 68 (73%) |
| Age (years) | 59 (12) |
| Height (m) | 1.69 (0.90) |
| Weight (kg) | 76.4 (12.3) |
| Smoking | |
| Never smoked | 35 (38%) |
| Previous smoker | 51 (55%) |
| Present smoker | 7 (8%) |
| Fulfills ACSM/AHA recommendations | 29 (31%) |
| Disease duration (years) | 12 (9) |
| Seropositive (anti-citrullinated peptide antibody and/or rheumatoid factor positive) | 75 (81%) |
| Uses conventional DMARD | 74 (80%) |
| Uses biological DMARD | 54 (58%) |
| DAS28 | 2.56 (1.04) |
| mHAQ | 0.26 (0.31) |
| Peak oxygen uptake (mL × min−1 × kg−1) | 32.2 (9.6) |
Data are given as number (percent) or mean (SD). Some of the data for persons with rheumatoid arthritis have been published previously [23]
ACSM American College of Sports Medicine, AHA American Heart Association, DAS28 disease activity score including high-sensitivity C-reactive protein concentration, DMARD disease-modifying antirheumatic drug, mHAQ modified Health Assessment Questionnaire